Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...
WTVD

Moderna COVID vaccine performs as well in children as it does in adults, company says

CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...
FOX 10 Phoenix

Study shows Moderna’s COVID-19 vaccine could lead to more side effects than Pfizer/BioNTech’s

New research from the U.S. Centers for Disease Control and Prevention suggests that people who receive Moderna’s COVID-19 vaccine might experience more side effects than those who get ...
abc13

Here's why some are experiencing side effects after 2nd Pfizer or Moderna vaccine shot

SAN FRANCISCO -- As more people are eligible to get vaccinated, reports of side effects after the second Pfizer and Moderna shots are surfacing. Dr. Robert Wachter, chief of medicine at UCSF says many ...
FierceBiotech

Moderna withdraws FDA filing for flu/COVID combination vaccine, plans resubmission with efficacy data

Moderna has pulled the filing for FDA approval of its flu/COVID combination vaccine. The biotech plans to resubmit later this year with the phase 3 flu vaccine efficacy data the agency wants to see.